Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Letter to HRSA on 340B Rebate Model
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
CSBA Letter to Congressional Leadership on…
BIO Comments to the USPTO’s MAY 10, 2024 Proposed…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
All Letters, Testimony & Comments
  • Show All
Search
Results
March 3, 2021
The Biotechnology Innovation Organization (BIO) applauds the introduction of the Emergency Relief for Farmers of Color Act and welcomes the inclusion of provisions from this legislation in the American Rescue Plan.  BIO is committed to…
February 26, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Department of Agriculture’s (USDA’s) advance notice of proposed rulemaking and request for public comment on a proposed framework for oversight of certain…
February 26, 2021
Equality of opportunity is a key pillar of our great democracy—one that allows all people to pursue their American Dream—and part of what makes our nation exceptional. Our industries, representing and employing tens of millions of Americans,…
February 25, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture hearing entitled, "Climate Change and the U.S. Agriculture and Forestry Sectors." BIO…
February 21, 2021
On behalf of the Biotechnology Innovation Organization (BIO) – the world’s largest trade group for the biotechnology sector – I write to express support for Senate File 944, a bill you recently filed that would increase the minimum biofuel content…
February 9, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "Back in Action…
February 5, 2021
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time.  The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch…
January 28, 2021
Section 182 of the Trade Act of 1974, known as the “Special 301” provisions, requires the United States Trade Representative to identify countries that deny adequate and effective intellectual property protections or fair and equitable market access…
January 26, 2021
The undersigned food and agriculture trade associations respectfully urge confirmation of Katherine Tai to be U.S. Trade Representative. Our associations represent the vast majority of the food and agriculture sector accounting for roughly one…
January 25, 2021
On behalf of the Biotechnology Innovation Organization (BIO), the nearly 1000 companies, universities, and biotech organizations we represent comprised of millions of scientists, researchers and entrepreneurs, congratulations on your historic…